# A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)

> **NCT01136954** · PHASE3 · COMPLETED · sponsor: **Eisai Limited** · enrollment: 144 (actual)

## Conditions studied

- Partial Seizures

## Interventions

- **DRUG:** Zonisamide

## Key facts

- **NCT ID:** NCT01136954
- **Lead sponsor:** Eisai Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-07
- **Primary completion:** 2012-01
- **Final completion:** 2012-03
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2016-01-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136954

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136954, "A Study to Assess the Efficacy and Safety of Adjunctive Zonisamide in Paediatric Partial Onset Seizures (CATZ Extension Study)". Retrieved via AI Analytics 2026-07-20 from https://api.ai-analytics.org/clinical/NCT01136954. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*